IL-7 uniquely maintains FoxP3 + adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization

Journal of Autoimmunity

Volumn 37, Issue 3, 2011, Pages 217-227

  Li, Cheng Rui ^a   Deiro, Mia F ^a   Godebu, Elana ^b   Bradley, Linda M ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Diabetes; IL 7; Integrin 7; NOD mouse; Regulatory T cell

Indexed keywords

BETA7 INTEGRIN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; HOMEOSTASIS; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL MOVEMENT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INTEGRIN BETA CHAINS; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; PANCREAS; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 80755139636     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.06.002     Document Type: Article

References (60)

1. Stadinski B., Kappler J., Eisenbarth G.S. Molecular targeting of islet autoantigens. Immunity 2010, 32:446-456.
2. Wing K., Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010, 11:7-13.
3. Bluestone J.A., Abbas A.K. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003, 3:253-257.
4. Josefowicz S.Z., Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009, 30:616-625.
5. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004, 199:1455-1465.
6. + regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009, 39:1088-1097.
7. + Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009, 31:772-786.
8. Zhou X., Bailey-Bucktrout S.L., Jeker L.T., Penaranda C., Martinez-Llordella M., Ashby M., et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009, 10:1000-1007.
9. Rochman Y., Spolski R., Leonard W.J. New insights into the regulation of T cells by gamma© family cytokines. Nat Rev Immunol 2009, 9:480-490.
10. Setoguchi R., Hori S., Takahashi T., Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005, 201:723-735.
11. Dendrou C.A., Wicker L.S. The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice. J Clin Immunol 2008, 28:685-696.
12. Wicker L.S., Clark J., Fraser H.I., Garner V.E., Gonzalez-Munoz A., Healy B., et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun 2005, 25(Suppl):29-33.
13. Weber S.E., Harbertson J., Godebu E., Mros G.A., Padrick R.C., Carson B.D., et al. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J Immunol 2006, 176:4730-4739.
14. + regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 2009, 10:689-695.
15. - T cells of healthy and type 1 diabetic subjects. Eur J Immunol 2009, 39:612-620.
16. Godebu E., Summers-Torres D., Lin M.M., Baaten B.J., Bradley L.M. Polyclonal adaptive regulatory CD4 cells that can reverse type I diabetes become oligoclonal long-term protective memory cells. J Immunol 2008, 181:1798-1805.
17. Tough D.F., Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med 1994, 179:1127-1135.
18. Judkowski V., Pinilla C., Schroder K., Tucker L., Sarvetnick N., Wilson D.B. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J Immunol 2001, 166:908-917.
19. Kondrack R.M., Harbertson J., Tan J.T., McBreen M.E., Surh C.D., Bradley L.M. Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 2003, 198:1797-1806.
20. + Treg revert in vivo and do not protect from experimental GVHD. Eur J Immunol 2009, 39:3091-3096.
21. Mazzucchelli R., Hixon J.A., Spolski R., Chen X., Li W.Q., Hall V.L., et al. Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP. Blood 2008, 112:3283-3292.
22. + cells. J Exp Med 2002, 195:1523-1532.
23. van Leeuwen E.M., Sprent J., Surh C.D. Generation and maintenance of memory CD4(+) T Cells. Curr Opin Immunol 2009, 21:167-172.
24. Murai M., Turovskaya O., Kim G., Madan R., Karp C.L., Cheroutre H., et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009, 10:1178-1184.
25. Wan Y.Y., Flavell R.A. Regulatory T cells, transforming growth factor-beta, and immune suppression. Proc Am Thorac Soc 2007, 4:271-276.
26. Li M.O., Flavell R.A. TGF-beta: a master of all T cell trades. Cell 2008, 134:392-404.
27. Hanninen A., Taylor C., Streeter P.R., Stark L.S., Sarte J.M., Shizuru J.A., et al. Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest 1993, 92:2509-2515.
28. Faveeuw C., Gagnerault M.C., Lepault F. Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice. J Immunol 1994, 152:5969-5978.
29. Yang X.D., Michie S.A., Tisch R., Karin N., Steinman L., McDevitt H.O. A predominant role of integrin alpha 4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A 1994, 91:12604-12608.
30. Yang X.D., Sytwu H.K., McDevitt H.O., Michie S.A. Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice. Diabetes 1997, 46:1542-1547.
31. + regulatory T cells. J Exp Med 2004, 199:303-313.
32. + regulatory T cells: more of the same or a division of labor?. Immunity 2009, 30:626-635.
33. Chung C.H., Levine F. Adult pancreatic alpha-cells: a new source of cells for beta-cell regeneration. Rev Diabet Stud 2010, 7:124-131.
34. Willcox A., Richardson S.J., Bone A.J., Foulis A.K., Morgan N.G. Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes. Diabetologia 2010, 53:2020-2028.
35. Tang Q., Adams J.Y., Penaranda C., Melli K., Piaggio E., Sgouroudis E., et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 2008, 28:687-697.
36. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
37. Sharma M.D., Hou D.Y., Baban B., Koni P.A., He Y., Chandler P.R., et al. Reprogrammed Foxp3(+) regulatory T cells provide essential Help to support Cross-presentation and CD8(+) T cell Priming in naive mice. Immunity 2010, 33:942-954.
38. Ablamunits V., Bisikirska B.C., Herold K.C. Human regulatory CD8 T cells. Ann NY Acad Sci 2008, 1150:234-238.
39. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004, 199:1467-1477.
40. + regulatory T cells. Proc Natl Acad Sci U S A 2007, 104:2821-2826.
41. Harbertson J., Biederman E., Bennett K.E., Kondrack R.M., Bradley L.M. Withdrawal of stimulation may initiate the transition of effector to memory CD4 cells. J Immunol 2002, 168:1095-1102.
42. + regulatory T cells in the human immune system. Nat Rev Immunol 2010, 10:490-500.
43. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006, 212:8-27.
44. + T regulatory cells. J Immunol 2008, 181:225-234.
45. + regulatory T cell development. J Immunol 2008, 181:3285-3290.
46. Merkenschlager M., von Boehmer H. PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J Exp Med 2010, 207:1347-1350.
47. Lim S.P., Leung E., Krissansen G.W. The beta7 integrin gene (Itgb-7) promoter is responsive to TGF-beta1: defining control regions. Immunogenetics 1998, 48:184-195.
48. Hanninen A., Salmi M., Simell O., Jalkanen S. Endothelial cell-binding properties of lymphocytes infiltrated into human diabetic pancreas. Implications for pathogenesis of IDDM. Diabetes 1993, 42:1656-1662.
49. + cytolytic T lymphocytes. Transplantation 1999, 67:1418-1425.
50. Siegmund K., Feuerer M., Siewert C., Ghani S., Haubold U., Dankof A., et al. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 2005, 106:3097-3104.
51. Annacker O., Coombes J.L., Malmstrom V., Uhlig H.H., Bourne T., Johansson-Lindbom B., et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med 2005, 202:1051-1061.
52. Feng Y., Wang D., Yuan R., Parker C.M., Farber D.L., Hadley G.A. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells. J Exp Med 2002, 196:877-886.
53. Kilshaw P.J., Higgins J.M. Alpha E: no more rejection?. J Exp Med 2002, 196:873-875.
54. Tonkin D.R., He J., Barbour G., Haskins K. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo. J Immunol 2008, 181:4516-4522.
55. Riley J.L., June C.H., Blazar B.R. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 2009, 30:656-665.
56. Vendrame F., Pileggi A., Laughlin E., Allende G., Martin-Pagola A., Molano R.D., et al. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 2010, 59:947-957.
57. + T reg cells. J Exp Med 2006, 203:1701-1711.
58. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006, 203:1693-1700.
59. Long S.A., Cerosaletti K., Bollyky P.L., Tatum M., Shilling H., Zhang S., et al. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes 2010, 59:407-415.
60. Dromey J.A., Lee B.H., Yu H., Young H.E., Thearle D.J., Jensen K.P., et al. Generation and expansion of regulatory human CD4(+) T-cell clones specific for pancreatic islet autoantigens. J Autoimmun 2011, 36:47-55.